Our first SensiScreen assays for metastatic colorectal cancer (mCRC) and melanoma patients are CE IVD certified and the most sensitive, robust and easy to use real-time PCR based assays in the field. Learn more ›
PlentiPlex® MSI assays are intended for in vitro diagnosis of impaired DNA mismatch repair system (MMR) affecting prognosis and selection of treatment in cancer patients. PlentiPlex® MSI assays offer two different multiplexed MSI assays for the length analysis of five micro-satellite loci. The mono- and di-nucleotide panel recommended by the Bethesda guidelines and, the Pentaplex mono-nucleotide panel introduced by Hamelin, enabling evaluation of MMR status on DNA sequencer instruments. Learn more ›
Our custom DNA oligos are specified to your needs, with thorough and careful quality control and quick turnaround, we ensure quality oligos. Learn more ›
Eurostars project together with Danish Technological Institute and Istituto Cantonale Di Patologia ranked as #1 application in 2013.
Using novel DNA chemistry we will develop diagnostic kits tailor-made for Lung Cancer fulfilling the need for extreme sensitivity for the limited amount of cancer material. The kit prototypes will be validated on clinical samples. A kit for following patient during treatment is also developed. Learn more ›
Ministerial delegation visit from Croatia
"I am pleased with everything I have seen and with the hospitality extended to me and my colleagues during our stay in Denmark. We are grateful to the Healthcare DENMARK team for being wonderful hosts to us and for the excellent organization of our visit."
- Dario Nakić, Croatian Minister of Health